Alacizumab - HY-P990318

Catalog #
HY-P990318
 
Alacizumab is a CHO-expressed humanized antibody that targets VEGFR2/KDR/CD309. Alacizumab contains huIgG1 heavy chain and huκ light chain, with a predicted molecular weight (MW) of 144.08 kDa. The isotype control for Alacizumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
Weitere Informationen
Datasheet URL http://file.medchemexpress.com/batch_PDF/HY-P990318/Alacizumab-DataSheet-MedChemExpress.pdf
Quantity Getquote
Shipping Room temperature
Application COVID-19-immunoregulation
Clinical Information No Development Reported
Target Others
Applications
Application: COVID-19-immunoregulation

Newsletter
abonnieren

15% Rabatt

erhalten